Search research articles
Contact Us
Filters
Showing results (561-570 of 654) with videos related to
Page
of 66
Sort By:
Journal of Addiction Medicine
|
November 20, 2021
Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis
Brittany B Dennis, Leslie J Martin, Leen Naji, et al.
Journal of Medicinal Chemistry
|
March 4, 2005
Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity
Andrew J Souers, Ju Gao, Michael Brune, et al.
Bone Marrow Transplantation
|
March 24, 2015
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
A Sureda, P Bader, S Cesaro, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 10, 2006
Identification and characterization of amino-piperidinequinolones and quinazolinones as MCHr1 antagonists
Christopher Blackburn, Matthew J LaMarche, James Brown, et al.
Biochemical and Biophysical Research Communications
|
August 14, 1996
Novel azacyclic ureas that are potent inhibitors of HIV-1 protease
H L Sham, C Zhao, K C Marsh, et al.
Bioorganic & Medicinal Chemistry
|
August 30, 2008
Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists
Brian S Brown, Ryan Keddy, Guo Zhu Zheng, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 1, 2008
Synthesis and SAR of novel, potent and orally bioavailable benzimidazole inhibitors of poly(ADP-ribose) polymerase (PARP) with a quaternary methylene-amino substituent
Gui-Dong Zhu, Viraj B Gandhi, Jianchun Gong, et al.
European Journal of Pharmacology
|
March 19, 1999
Pharmacology of A-216546: a highly selective antagonist for endothelin ET(A) receptor
J R Wu-Wong, D B Dixon, W J Chiou, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1997
Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir
D J Kempf, K C Marsh, G Kumar, et al.
Journal of Medicinal Chemistry
|
August 14, 1998
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546)
G Liu, K J Henry, B G Szczepankiewicz, et al.
Page
of 66
Search research articles
Search
Showing results (561-570 of 654) with videos related to
Sort By:
Page
of 66
Journal of Addiction Medicine
|
November 20, 2021
Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis
Brittany B Dennis, Leslie J Martin, Leen Naji, et al.
Journal of Medicinal Chemistry
|
March 4, 2005
Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity
Andrew J Souers, Ju Gao, Michael Brune, et al.
Bone Marrow Transplantation
|
March 24, 2015
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
A Sureda, P Bader, S Cesaro, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 10, 2006
Identification and characterization of amino-piperidinequinolones and quinazolinones as MCHr1 antagonists
Christopher Blackburn, Matthew J LaMarche, James Brown, et al.
Biochemical and Biophysical Research Communications
|
August 14, 1996
Novel azacyclic ureas that are potent inhibitors of HIV-1 protease
H L Sham, C Zhao, K C Marsh, et al.
Bioorganic & Medicinal Chemistry
|
August 30, 2008
Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists
Brian S Brown, Ryan Keddy, Guo Zhu Zheng, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 1, 2008
Synthesis and SAR of novel, potent and orally bioavailable benzimidazole inhibitors of poly(ADP-ribose) polymerase (PARP) with a quaternary methylene-amino substituent
Gui-Dong Zhu, Viraj B Gandhi, Jianchun Gong, et al.
European Journal of Pharmacology
|
March 19, 1999
Pharmacology of A-216546: a highly selective antagonist for endothelin ET(A) receptor
J R Wu-Wong, D B Dixon, W J Chiou, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1997
Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir
D J Kempf, K C Marsh, G Kumar, et al.
Journal of Medicinal Chemistry
|
August 14, 1998
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546)
G Liu, K J Henry, B G Szczepankiewicz, et al.
Page
of 66